GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Other Income (Expense)

Organon Pharma Indonesia PT (ISX:SCPI) Other Income (Expense) : Rp Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Other Income (Expense)?

Organon Pharma Indonesia PT's other income expense for the Organon Pharma Indonesia PT's pretax income for the three months ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Other Income (Expense) Historical Data

The historical data trend for Organon Pharma Indonesia PT's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Other Income (Expense) Chart

Organon Pharma Indonesia PT Annual Data
Trend
Other Income (Expense)

Organon Pharma Indonesia PT Quarterly Data
Other Income (Expense)

Organon Pharma Indonesia PT Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.


Organon Pharma Indonesia PT  (ISX:SCPI) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines